Pyxis Oncology Ownership | Who Owns Pyxis Oncology?

Overview Forecast RevenueFinancials Chart

Pyxis Oncology Ownership Summary

Pyxis Oncology is owned by 53.38% institutional investors, 13.53% insiders, and 33.09% retail investors. Pfizer is the largest institutional shareholder, holding 11.32% of PYXS shares. Vanguard MStar Total Stk Mkt Idx Invest is the top mutual fund, with 2.54% of its assets in Pyxis Oncology shares.

PYXS Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Pyxis Oncology	53.38%	13.53%	33.09%
Sector	Healthcare Stocks	244.59%	12.11%	-156.70%
Industry	Biotech Stocks	379.61%	11.70%	-291.31%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Pfizer	7.03M	11.32%	$9.21M
Laurion capital management lp	5.00M	8.04%	$7.30M
Blackrock	2.79M	5.43%	$9.22M
Tang capital management	2.50M	4.04%	$5.55M
Vanguard group	2.34M	3.73%	$2.69M
Perceptive advisors	1.18M	1.90%	$2.62M
Palo alto investors lp	1.01M	1.63%	$1.48M
683 capital management	896.26K	1.44%	$1.31M
Renaissance	888.68K	1.43%	$1.30M
Blackrock funding, inc. /de	788.84K	1.27%	$1.15M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Ridgeback capital investments	359.23K	100.00%	$560.40K
Pfizer	7.03M	3.86%	$9.21M
Healthinvest partners ab	197.04K	0.52%	$1.62M
Laurion capital management lp	5.00M	0.32%	$7.30M
Stempoint capital lp	689.54K	0.31%	$1.53M
Palo alto investors lp	1.01M	0.23%	$1.48M
Tang capital management	2.50M	0.21%	$5.55M
Diadema partners lp	150.00K	0.09%	$333.00K
Perceptive advisors	1.18M	0.08%	$2.62M
Decheng capital	326.81K	0.07%	$477.14K

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	2.79M	0.00%	2.46M
Perceptive advisors	1.18M	0.08%	1.18M
Stempoint capital lp	689.54K	0.31%	689.54K
Jacobs levy equity management	461.00K	0.00%	461.00K
Driehaus capital management	418.63K	0.01%	418.63K

Top Sellers

Holder	Shares	% Assets	Change
Deep track capital, lp	-	-	-4.18M
Blue owl capital lp	-	-	-1.13M
Abrdn	-	-	-913.04K
Ikarian capital	-	-	-613.25K
Superstring capital management lp	-	-	-484.44K

New Positions

Holder	Shares	% Assets	Change	Value
Perceptive advisors	1.18M	0.08%	1.18M	$2.62M
Stempoint capital lp	689.54K	0.31%	689.54K	$1.53M
Driehaus capital management	418.63K	0.01%	418.63K	$929.36K
Ridgeback capital investments	359.23K	100.00%	359.23K	$560.40K
Vanguard fiduciary trust	300.90K	0.00%	300.90K	$439.31K

Sold Out

Holder	Change
Golden state equity partners	-10.00
Northwestern mutual wealth management	-12.00
Ifp advisors	-17.00
West branch capital	-25.00
Russell investments group	-64.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2026	83	2.47%	34,161,274	23.91%	53	2.83%	38	46.15%	23	-34.29%
Mar 31, 2026	47	-41.98%	18,085,721	-40.11%	29	1.25%	19	-60.42%	14	-12.50%
Dec 31, 2025	42	-43.24%	19,885,511	-25.88%	31	1.69%	26	-3.70%	6	-79.31%
Sep 30, 2025	71	-1.39%	23,143,075	-14.35%	37	1.91%	26	-25.71%	29	26.09%
Jun 30, 2025	74	-17.78%	27,483,617	-9.00%	45	1.84%	36	9.09%	23	-14.81%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard MStar Total Stk Mkt Idx Invest	1.61M	2.54%	189.74K
Vanguard Morn Total Stk Mkt Idx Investor	1.42M	2.24%	-
Vanguard Total Stock Mkt Idx Inv	1.42M	2.24%	-
abrdn Healthcare Investors	626.64K	1.01%	-
Vanguard Institutional Extnd Mkt Idx Tr	600.18K	0.95%	-
HealthInvest Sustainable Healthcare E	593.96K	0.94%	-
Fidelity Small Cap Index	499.46K	0.81%	-
iShares Russell 2000 Value ETF	464.56K	0.75%	-
iShares Biotechnology ETF	386.05K	0.61%	-1.18K
HealthInvest S&M Cap Healthcare C	372.50K	0.59%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 30, 2026	Dupont Jakob	-	Sell	$107.10K
Apr 14, 2025	HUMPHREY RACHEL	-	Sell	$1.36K
Apr 17, 2025	HUMPHREY RACHEL	-	Sell	$194.00
Apr 21, 2025	HUMPHREY RACHEL	-	Sell	$14.36K
Nov 26, 2024	Connealy Pamela Ann	CFO & COO	Buy	$163.46K

Insider Transactions Trends

Date	Buy	Sell
2026 Q3	-	-
2026 Q2	-	1
2026 Q1	-	-
2025 Q1	-	-
2024 Q4	2	-

PYXS Ownership FAQ

Who Owns Pyxis Oncology?

Pyxis Oncology shareholders are primarily institutional investors at 53.38%, followed by 13.53% insiders and 33.09% retail investors. The average institutional ownership in Pyxis Oncology's industry, Biotech Stocks , is 379.61%, which Pyxis Oncology falls below.

Who owns the most shares of Pyxis Oncology?

Pyxis Oncology’s largest shareholders are Pfizer (7.03M shares, 11.32%), Laurion capital management lp (5M shares, 8.04%), and Blackrock (2.79M shares, 5.43%). Together, they hold 24.79% of Pyxis Oncology’s total shares outstanding.

Does Blackrock own Pyxis Oncology?

Yes, BlackRock owns 5.43% of Pyxis Oncology, totaling 2.79M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 9.22M$. In the last quarter, BlackRock increased its holdings by 2.46M shares, a 766.09% change.

Who is Pyxis Oncology’s biggest shareholder by percentage of total assets invested?

Ridgeback capital investments is Pyxis Oncology’s biggest shareholder by percentage of total assets invested, with 100.00% of its assets in 359.23K Pyxis Oncology shares, valued at 560.4K$.

Who is the top mutual fund holder of Pyxis Oncology shares?

Vanguard MStar Total Stk Mkt Idx Invest is the top mutual fund holder of Pyxis Oncology shares, with 2.54% of its total shares outstanding invested in 1.61M Pyxis Oncology shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools